Silvia Park

9PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesGenetic immunologyModels of care and place of birthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 26, 2026
Real-World Outcomes of Tisagenlecleucel Versus Standard-of-Care Salvage Chemotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Analysis From Korea.

|Apr 16, 2026
Individualized decitabine dosing for post-HSCT maintenance in MDS and secondary AML from MDS: long-term outcomes from the PODAC trial and matched controls.

|Sep 09, 2023
Development of cost-effective and fast KIR genotyping by multiplex PCR-SSP.

Eun-Jeong Choi, In-Cheol Baek, Silvia Park

|Oct 08, 2022
Five-day versus 7-day treatment regimen with azacitidine in lower risk myelodysplastic syndrome: A phase 2, multicenter, randomized trial.

Silvia Park, So Yeon Park, Je-Hwan Lee

|Mar 28, 2022
A retrospective comparison of salvage intensive chemotherapy versus venetoclax-combined regimen in patients with relapsed/refractory acute myeloid leukemia (AML).

Silvia Park, Daehun Kwag, Tong Yoon Kim

|Sep 30, 2021
Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome.

Silvia Park, Tong Yoon Kim, Jong Hyuk Lee

Pageof 2

Frequent Collaborators

5 joint publications

Sung Soo Park

4 joint publications

Hee-Je Kim

4 joint publications

Yoo-Jin Kim

3 joint publications

Byung-Sik Cho